Friday, 25 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14483
Articles
Company
Deals
NeuExcell Therapeutics Secures Over $14.5 Million in Pre-Series A+ Funding for Neurological Treatments
December 21, 2024
Company
Drug
Transcenta’s Osemitamab Achieves Full Enrollment in Phase II Gastric Cancer Study
December 21, 2024
Company
Drug
TYK Medicines’ TY-9591 Gains CDE Green Light for Pivotal Phase II Study in NSCLC with Brain Metastases
December 21, 2024
Policy / Regulatory
NMPA Transitions Desloratadine, Loratadine, Ambroxol, and Naproxen to OTC Status
December 21, 2024
Company
Drug
Skyline Therapeutics Reports Positive Preclinical Results for SKG0106 and SKG0201 Gene Therapies
December 21, 2024
Company
Deals
Cellular Biomedicine Group Inc. and Janssen Biotech, Inc. Announce Global Collaboration for CAR-T Therapies
December 21, 2024
Policy / Regulatory
Chinese Authorities Launch Special Campaign to Combat Fraud in Medical Insurance
December 21, 2024
Company
Deals
Johnson & Johnson’s Kenvue IPO Raises USD 3.8 Billion, Marking Year’s Largest US IPO
December 21, 2024
Company
Full-Life Technologies Ltd to Establish GMP-Compliant Radiopharmaceutical Plant in Belgium’s Wallonie Region
December 21, 2024
Policy / Regulatory
China’s CDE Unveils Technical Guidelines for Stem Cell Products and Immunotherapy in Chronic Hepatitis B
December 21, 2024
Company
Drug
Q1 2023 financial report: AstraZeneca leads innovation in China, Sanofi’s sales in China decline
December 21, 2024
Company
Drug
CMS Receives NMPA Approval for Clinical Study of Tetravalent BsAb for nAMD
December 21, 2024
1
2
…
981
982
983
984
985
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?